Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Adriana G. Ioachimescu MD, PhD
Professor
Department of Medicine
Division of Endocrinology

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226
Fax: 414-955-0067

EDUCATION:
1989 - 1995 MD, Carol Davila University of Medicine, Bucharest, Romania
1997 - 2001 PhD, Carol Davila University of Medicine, Bucharest, Romania

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1996 - 2000 Internal Medicine Residency and Endocrinology Fellowship, Carol Davila University of Medicine, Bucharest, Romania
2002 - 2003 Internal Medicine Residency (PGY1-2), Danbury Hospital, CT
2003 - 2004 Internal Medicine Residency (PGY3), Cleveland Clinic, OH
2004 - 2006 Endocrinology Fellowship, Cleveland Clinic, OH

FACULTY APPOINTMENTS:
1996 - 2001 Assistant Professor, Endocrinology, Carol Davila University, Bucharest, Romania
2007 - 2013 Assistant Professor of Medicine/Neurological Surgery, Emory University School of Medicine
2013 - Present Adjunct Professor of Medicine/Neurological Surgery, Endocrinology, Emory University School of Medicine
2013 - 2018 Associate Professor of Medicine/Neurological Surgery, Emory University School of Medicine
2018 - 2022 Professor of Neurological Surgery, Emory University School of Medicine
2018 - 2022 Professor of Medicine, Endocrinology, Metabolism and Lipids, Emory University School of Medicine
01/2023 - Present Professor of Medicine with joint appointment in Neurosurgery, Medicine, Endocrinology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226
01/2023 - Present Adjunct Professor of Neurological Surgery, Emory University School of Medicine
06/2023 - Present Director for Pituitary and Adrenal Disease Program, Medicine, Froedtert and Medical College of Wisconsin

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
2006 - 2007 Clinical Associate Staff, Endocrinology, Cleveland Clinic, Cleveland, OH
2007 - 2008 Attending, Endocrinology and Internal Medicine, Grady Memorial Hospital
2008 - 2022 Attending Endocrinologist, Emory University Hospital
01/2023 - Present Attending Physician, Froedtert Hospital, Milwaukee, WI

RESEARCH ADMINISTRATIVE APPOINTMENTS:
2009 - 2012 Research Appointment Work Without Compensation, Atlanta VA Hospital, Decatur, GA

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Romanian Health Ministry Certification in Endocrinology
2000
None
Internal Medicine Certification
2004
None
Endocrinology Certification
2006
None
Endocrinology Recertification
2016
None
   
Licensure
Number Issue DateExpiration
Ohio Medical License
2005
2008
Georgia Medical License
2007
2024
Wisconsin Medical License
2023
None
    

AWARDS AND HONORS:
2005 Young Investigator Award, Honorable Mention, AACE
2006 Young Investigator Award, First Prize, AACE
2008 Mara Lieberman Award for outstanding abstracts submitted by women at the Annual Endocrine Society Meeting, Endocrine Society
2010 Fellow, American College of Endocrinology
2010 Mentor of the Year Award, Endocrinology , Emory University
2015 Mentor of the Year Award, Endocrinology, Emory University
2015 Provider Award for patient satisfaction, top 10% Press Ganey scores, Press Ganey
2016 Platinum Provider Award for patient satisfaction, top 10% Press Ganey scores, Press Ganey
01/2018 - 04/2018 Woodruff Leadership Academy fellowship
03/2018 Emory School of Medicine recognition for outstanding work, National Doctor's Day
2019 Educator Appreciation Day Recognition, Emory School of Medicine
2022 Top Doctors, Castle Connolly
2022 9th Annual Celebration of Faculty Eminence (nominated to represent the department of Neurosurgery for outstanding dedication to the mission of the Emory School of Medicine), Emory School of Medicine
2022 Educator Appreciation Day Recognition, Emory School of Medicine
2024 Medical Student Teaching Award, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1997 - Present Romanian Society for PsychoNeuroEndocrinology
2005 - Present American Association of Clinical Endocrinology (AACE)
2005 - Present Endocrine Society
2006 - 2011 American Diabetes Association
2008 - Present Pituitary Society
2011 - 2018 Southern Society of Clinical Investigation
2012 - 2021 American Federation for Medical Research

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
2015 - 2017 Associate Editor, Pituitary and Adrenal, Acta Endocrinologica
2016 - 2022 Consultant Editor, Endocrinology and Metabolism Clinics of North America
2016 - 2022 Endocrinology and Metabolism Clinics of North America
2019 - 2021 Acta Endocrinologica
2021 - Present Associate Editor, Endocrine Reviews
2022 Book Editor, Pituitary throughout the life cycle, Springer, ISBN 978-3-030-99917-9
2022 Editor of Special Issue, Personalized management of acromegaly, Frontiers in Endocrinology
Editorial Board
2015 - 2019 Journal of Investigative Medicine
2016 - Present Pituitary
2020 - Present Reviews in Endocrinology and Metabolism Disorders
2021 - 2022 Journal of the Endocrine Society
2022 Special issue, Frontiers in Endocrinology, "Personalized Management of Acromegaly"
2022 Book editor, Springer, Pituitary throughout the life cycle, ISBN 978-3-030-99917-9 (print) and 978-3-030-99918-6 (e-book)
2024 Special issue, Reviews in Endocrinology and Metabolism, "Hypoprolactinemia"

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2009 - 2022 Endocrinology Division Core Fellowship Committee, Emory Clinic
2009 - 2011 Co-Chair, Department of Medicine Mentoring Committee, Emory University Department of Medicine
2010 - 2011 Department of Medicine Faculty Development Committee, Emory University Department of Medicine
2012 - 2015 Board of Directors, Georgia Chapter, AACE
2012 - 2013 President Elect, Southern American Federation for Medical Research
2013 - 2014 President, Southern American Federation for Medical Research
2015 - 2016 Secretary, Georgia Chapter, AACE
2015 - 2018 Care Team Optimization Leader Committee, Emory Clinic
2016 - 2017 President Elect, Georgia Chapter, AACE
2017 - 2018 Immediate Past President, Georgia Chapter, AACE
2017 - 2018 President, Georgia Chapter, AACE
2018 - 2019 Electronic Order Entry Cleanup Initiative Committee, Emory Clinic
2020 - 2022 Telemedicine at Brain Health Center Committee, Emory Healthcare
2024 - Present Department of Medicine Faculty Promotion Committee, Medical College of Wisconsin

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2012 - 2015 Clinical Research Committee, American Association of Clinical Endocrinologists
2014 - 2017 National Counselor at Large, American Federation for Medical Research
2015 - 2019 Board of Directors, Pituitary Society
2015 Moderator, Acromegaly Consensus Conference
2017 - 2018 Neuroendocrine and Pituitary Scientific Committee, AACE
2017 - Present Scientific Advisory Board, Pituitary Network Association
2017 - Present Chair, Early Career Development Committee, Pituitary Society
2018 - 2019 Pituitary, Gonad, Adrenal and Neuroendocrine Disease State Network Committee, AACE
2018 - 2019 Pituitary Congress Planning Committee
2018 Moderator, 12th Acromegaly Consensus Conference: Diagnosis and Treatment of Acromegaly Comorbidities. An Update
2019 - 2022 Vice-Chair, Pituitary, Gonad, Adrenal and Neuroendocrine Disease State Network, AACE
2019 - 2020 Nominating Committee, AACE
2019 - 2020 Award Task Force, AACE
2019 Moderator, 13th Acromegaly Consensus Conference “Global Acromegaly Management”
2020 Group Leader, Cushing’s disease consensus conference
2020 - 2021 Vice-Chair, Annual Scientific Meeting Planning Committee of the AACE
2020 - 2021 Financial Committee, AACE
2021 - 2022 Chair-Elect, Annual Scientific Meeting Planning Committee, AACE
2022 - 2023 Chair, Annual Scientific Meeting Planning Committee, AACE
2022 Moderator, Acromegaly Consensus Conference
2022 - 2023 Chair, Scientific Committe of the American Association of Clinical Endocrinology Annual Meeting
2022 - Present Writer, Pituitary Section, Endocrine Self-Assessment Program (ESAP)
2023 Moderator, Acromegaly Consensus Conference "medical Treatment: why, when, and how"
09/10/2024 - 09/11/2024 Chair of a Breakout Session, 16th Consensus Conference of Acromegaly
2024 - Present Chair, Education Oversight Committee, American Association of Clinical Endocrinology
2024 - Present ex officio member, Board of Trustees, American Association of Clinical Endocrinology

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Investigator-initiated study: Brain alterations in patients with Cushing’s disease
Source:
Recordati
Role & Effort:
Institutional Principal Investigator
Dates:
01/2024 - Present
Direct Funds:
$250,000
  
Title:
LINC6: Non-interventional study on osilodrostat in patients with endogenous Cushing’s syndrome
Source:
Recordati
Role & Effort:
Institutional Principal Investigator
Dates:
02/2024 - Present
  
Title:
Pituitary and Adrenal Disorders Related to Cortisol Dysregulation
Source:
CTSI Dual Focus Ensemble
Role & Effort:
Principal Investigator
Dates:
06/2024 - Present
Direct Funds:
$50,000
  
Prior
Peer Review
Title:
Outcomes of Surgical, Medical and Radiation Therapy for Pituitary Adenomas
Source:
Emory University
Role & Effort:
Principal Investigator
Dates:
2008
  
Title:
Growth Hormone Deficiency in Veterans with History of Traumatic Brain Injury
Source:
Novo Nordisk
Role & Effort:
Principal Investigator
Dates:
2009 - 2011
  
Title:
Somatuline Depot (Lanreotide) Injection for Acromegaly: a Post-marketing Observational Study (SODA)
Source:
Ipsen
Role & Effort:
Principal Investigator
Dates:
2011 - 2016
  
Title:
Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison with Nonfunctioning Pituitary Tumors
Source:
Ipsen
Role & Effort:
Principal Investigator
Dates:
2011 - 2016
  
Title:
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients with Cushing's Disease (Seascape)
Source:
Novartis
Role & Effort:
Principal Investigator
Dates:
2013 - 2015
  
Title:
Vocal assessment in patients with Cushing's disease and Acromegaly secondary to Pituitary Adenoma as compared to patients with non-functioning pituitary adenoma
Source:
Emory University
Role & Effort:
Co-Investigator
Dates:
2013 - 2015
  
Title:
An ACromegaly, open-label, multi-CEnter, Safety monitoring program for treating patients with SOM230 (pasireotide) LAR who have need to receive medical therapy (ACCESS)
Source:
Novartis
Role & Effort:
Principal Investigator
Dates:
2014 - 2015
  
Title:
A randomized, double-blind, multicenter, phase III study to evaluate the efficacy and safety of pasireotide LAR in patients with Cushing’s disease
Source:
Novartis
Role & Effort:
Principal Investigator
Dates:
2014 - 2017
  
Title:
A Phase III, multi-center, double-blind, randomized withdrawal study of LCI699 following a 24 week, single-arm, open-label dose titration and treatment period to evaluate the safety and efficacy of LCI699 for the treatment of patients with Cushing’s disease
Source:
Novartis
Role & Effort:
Principal Investigator
Dates:
2015 - 2020
  
Title:
Tumor markers in patients with Acromegaly and Cushing’s Disease
Source:
Emory University
Role & Effort:
Principal Investigator
Dates:
2016 - 2023
  
Title:
A phase 3, randomized, open-label, active controlled, multicenter study to evaluate maintenance of response, safety and patient reported outcomes in Acromegaly patients treated with standard of care parenteral somatostatin receptor ligands who previously tolerated and demonstrated a biochemical control on both treatments
Source:
Chiasma
Role & Effort:
Principal Investigator
Dates:
2016 - 2022
  
Title:
ACROSTUDY: A multicenter, post marketing surveillance study of pegvisomant therapy
Source:
Pfizer
Role & Effort:
Principal Investigator
Dates:
2016 - 2018
  
Title:
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of octreotide capsules in patients who previously tolerated and demonstrated biochemical control on injectable somatostatin receptor ligands
Source:
Chiasma
Role & Effort:
Principal Investigator
Dates:
2018 - 2020
  
Title:
A double-blind, placebo-controlled, randomized withdrawal following open-label therapy study to assess the safety and efficacy of levoketoconazole (2S, 4R-ketoconazole) in the treatment of endogenous Cushing’s syndrome
Source:
Strongbridge
Role & Effort:
Principal Investigator
Dates:
2018 - 2022
  
Title:
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing’s Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Source:
Novartis
PI:
Principal Investigator
Dates:
2019 - 2021
  
Title:
An open-label extension study of levoketoconazole 2S, 4R-ketoconazole) in the treatment of endogenous Cushing’s syndrome
Source:
Strongbridge
Role & Effort:
Principal Investigator
Dates:
2019 - 2022
  
Title:
(Management of Acromegaly) Registry MACRO
Source:
Chiasma/Amryt
Role & Effort:
Principal Investigator
Dates:
2020 - 2022
  
Title:
Cognitive and psychiatric functioning in Cushing’s disease versus nonfunctioning pituitary adenoma patients
Source:
Emory University
Role & Effort:
Co-Investigator
Dates:
2020 - 2024
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Acromegaly, Calcium and Bone, Grand Rounds in Endocrinology, University of Sao Paulo, Sao Paulo, Brazil, 2015
Updates on Pituitary Tumors, Grand Rounds in Endocrinology, Carol Davila University Bucharest, Romania, 2015
Acromegaly, Calcium and Bone, Grand Rounds in Endocrinology, Universitat Autonoma de Barcelona, Spain, 2016
Advances in Management of Pituitary Disorders, In-depth Symposia, First AACE Communities Middle East Hybrid Conference, Dubai, 2021
Personalized acromegaly management: Where are we in 2021, 16th Congress of Endocrinology, Diabetes and Metabolism, Medellin, Colombia, 2021
Update in Aggressive Pituitary Adenomas, Plenary Session, 24Th National Symposium of Pshychoneuroendocrinology, Romania, 2021
Hyperprolactinemia and its Multiple Facets, Best of AACE Annual 2024 Meeting - India Edition, virtual, 08/02/2024 - 08/03/2024
Arrhythmias and sleep apnea, 16th Consensus Conference on Acromegaly, Seville, Spain, 09/10/2024 - 09/11/2024
Central Diabetes Insipidus, Middle East and North Africa AAACE Conference, Dubai, - 11/2024
Challenging Cases, Middle East and North Africa AACE Conference, Dubai, - 11/2024
 
National
Acromegaly, Case Discussion, Cleveland Clinic 8th Annual Pituitary Conference, Cleveland, OH, 2012
Pituitary Surgery for and Medical Treatment of Acromegaly, Carolinas Chapter of the AACE, Hilton Head, SC, 2013
Acromegaly and Bone, Cleveland Clinic Grand Rounds in Endocrinology, Cleveland, OH, 2014
Acromegaly: Facets of the Disease, University of Virginia c in Endocrinology, Charlottesville, VA, 2015
A Critical Evaluation of Octreotide Capsules in Acromegaly, Endocrine Society Regional Live CME Programs, St Louis, MO and Atlanta, GA, 2016
Medical Treatment of Cushing’s Disease, UCLA city-wide endocrine club, Los Angeles, California, 2016
Cushing’s disease: predictors of postoperative outcomes, University of Southern California, Los Angeles, California, 2016
Acromegaly: an update, Baystate Medical Center, Adult and Pediatric Endocrinology Grand Rounds, Springfield, MA, 12/2017
Acromegaly: Lessons Learned, New York University, Adult and Pediatric Endocrinology Grand Rounds, New York, NY, 02/2018
Pituitary and Neuroendocrine Tumors: Diagnostic Challenges, Plenary Session, AACE, 05/2018
Acromegaly: What is New, Carolina’s AACE Annual Scientific Meeting, Kiawah Island, SC, 09/2018
Sui generis, Neuroscience Neurosurgery Lecture Series, Mayo Clinic, Jacksonville, FL, 12/2018
New Insights for Acromegaly Prevalence, Presentation, Age and Gender, Pituitary Congress, New Orleans, LA, 03/2019
Cushing’s Disease or the PseudoCushing’s State – Making the Diagnosis, Annual Southern California Pituitary Symposium at USC, Keck School of Medicine, Los Angeles, CA, 05/2019
Advances in the Management of Acromegaly, Annual Southern California Pituitary Symposium at USC, Keck School of Medicine, Los Angeles, CA, 05/2019
Medical management of acromegaly, Annual Southern California Pituitary Symposium at USC, Keck School of Medicine, Virtual Symposium, 08/2020
Can we predict outcomes in the treatment of Patients with Acromegaly, Pituitary Society Webinar, 2020
Acromegaly: lessons learned and future directions, Pacific Neurosciences Institute conference, 2020
Recent developments in the medical management of acromegaly, Update in Clinical Endocrinology of New York University Grossman School of Medicine, 2021
Age- and Sex-Specific differences in acromegaly, Special Grand Rounds, Medical College of Wisconsin, Milwaukee, WI, 2021
GH-secreting tumors: multifaceted presentations and outcomes, Endocrine Conference, Stanford University, 2022
Perioperative endocrine management for transsphenoidal surgery, Grand Rounds, Moffitt Cancer Center, 2023
Growth hormone secreting tumors: can we forecast treatment outcomes?, Cleveland Clinic (Ohio) grand rounds in endocrinology conference, Cleveland, OH, - 08/14/2024
"Diagnostic and treatment of neoplastic hypercortisolism", Endocrine Conference at Scripps, La Jolla, CA, - 04/19/2024
 
Regional
Pituitary and Adrenal Disorders, Emory University Internal Medicine Board Review Course, Atlanta, GA, 2008 - 2019
Hyperprolactinemia, Emory Pituitary Day. A Case-Based-Update on Pituitary Disorders, Atlanta, GA, 2008
Neuroendocrinology for the Pituitary Surgeon, Intraventricular and skull-based neuro-endoscopy course, Emory University, Atlanta, GA, 2009
Clinical Consequences of Hyponatremia in Hospital Medicine, 11th Annual Southern Hospital Medicine Conference, Atlanta, GA, 2010
Corticotroph Adenomas: From Silent to Cushing’s disease, Emory Pituitary Day. A Case-Based-Update on Pituitary Disorders, Atlanta, GA, 2011
Pituitary Diseases, Atlanta Medical Center, Internal Medicine Grand Rounds, Atlanta, GA, 2012
Non-tumoral Hyperprolactinemia, Georgia chapter of AACE scientific annual meeting, Atlanta, GA, 2014
How to Succeed as a Clinician-Educator?, Southern Regional Meeting “Meet the Professor” session, New Orleans, LA, 2017
Acromegaly, Calcium and Bone Metabolism, Augusta University Endocrine Conference, Augusta, GA, 2017
Hypercortisolemia: multiple facets, always challenging, Georgia AACE CME program, Atlanta, GA, 2018
 
Local
Grand Round Lectures in Endocrinology for Neurosurgery Residents and Fellows, 2008 - 2022
Assessment Strategies for the Obese Patient: The Lipid Accumulation Product, Endocrine Conference at Emory University, Atlanta, GA, 2008
Neuroendocrine Effects of Traumatic Brain Injury, Endocrine Conference, Emory University, Atlanta, GA, 2010
Pituitary Masses, Neurosurgery Grand Rounds, Emory University, Atlanta, GA, 2012
Predictors of Postoperative Remission in Patients with Functioning Pituitary Adenomas, Endocrine Conference, Emory University, Atlanta, GA, 2012
Pituitary Adenomas: an Update, Emory University Internal Medicine Grand Rounds, Atlanta, GA, 2013
Pituitary Adenomas. An Overview, ENT Grand Rounds, Emory University, Atlanta, GA, 2013
Pituitary Tumors: Overview and Implications on Fertility, Emory Reproductive Endocrinology Conference, Atlanta, GA, 2015
Acromegaly – Evaluation and Management, Emory Pediatric Endocrinology Conference, Atlanta, GA, 2015
General Endocrinology Emergencies, Emory Pulmonary Conference, Atlanta, GA, 2016
Effects of acromegaly on calcium and bone metabolism, Emory University Internal Medicine Grand Rounds, Atlanta, GA, 2016
Pituitary tumors 2018: the neuroendocrinologist perspective, Emory University Neurosurgery Grand Rounds, Atlanta, GA, 2018
Predictive modeling for pituitary adenomas, Endocrine Conference, Emory University, Atlanta, GA, 2019
Acromegaly in women, Reproductive Endocrinology Conference, Emory University, Atlanta, GA, 2020
Gender specific implications in Acromegaly, Endocrine Conference, Emory University, Atlanta, GA, 2021
Perioperative Endocrine Evaluation of Sellar and Suprasellar Masses, Neurosurgery Grand Rounds, Emory University, Atlanta, GA, 2021
GH-secreting tumors: multifaceted presentations and outcomes, Endocrine Conference, Stanford University, 2022
Management of ACTH - Dependent Hypercortisolism (Primary and Recurrence), 2023 Endocrine Surgery & Neuroendocrine Tumor Symposium, Milwaukee, WI, 2023
Brain altercations in hypercortisolism, MCW Neurosciences Research Center, Milwaukee, WI, 2023
Pituitary adenomas, MCW Internal Medicine Grand Rounds, Milwaukee, WI, 2023
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
International
Treating patients with acromegaly: what are your therapeutic options, Endocrine Society webinar, 04/28/2023
 
National
Abstract Reviewer, Endocrine Society, 97th Annual Meeting, San Diego, CA, 2015
 
Regional
Lead Abstract Reviewer, Southern Regional Meeting, New Orleans, LA, 2010 - 2013
Age and sex specific differences in acromegaly, Wayne State University Endocrine Grand Rounds, Virtual Conference, 05/31/2023
 

COMMITTEE SERVICE:
Medical College of Wisconsin
02/2023 - 03/2023 Poster Judge for Department of Medicine Research Retreat
11/2023 - Present member of the DOM promotion committee
 

MCW TEACHING ACTIVITIES:
Medical Student Education
- 11/2024 Health Sciences Summit
 
Resident and Fellow Education
- 2023 endocrine fellows' curriculum lectures: Acromegaly, Growth hormone deficiency, Hypopituitarism and Hypophysitis
 

EXTRAMURAL TEACHING:
Medical Student Education
1996 - 2000 Carol Davila University in Bucharest, MS4 supervision during their 4-week rotation in Endocrinology, 4 hours/week
2003 - 2007 Cleveland Clinic University/Case Western Learner College of Medicine and Pennsylvania State University, MS2-MS4 during Endocrinology rotations at Cleaveland Clinic, 1 hour/week
2007 - 2008 Grady, Bedside teaching attending, inpatient General Medicine rotations, 5 hours/week
04/2024 - Present MCW Fusion Endocrine & Reproduction Medical School (MS 1), Anterior Pituitary
 
Resident and Fellow Education
2006 - 2007 Cleveland, Bedside Teaching
2006 - 2007 Cleveland Clinic, Bedside teaching attending, inpatient and outpatient endocrinology rotations, 5 hours/week
2007 - 2023 Emory University, Core lectures, Endocrinology fellows (Adrenal Gland Testing, Pituitary tumors, Cushing’s syndrome, Water Metabolism Perturbations, Pituitary, Adrenal gland emergencies)
2007 - 2008 Grady Hospital, Atlanta, Bedside teaching
2007 - 2022 Emory University, Journal Club Weekly
2008 Emory University, Lectures in Endocrinology for Pulmonary Fellows
2008 - 2022 Emory University, Bedside teaching
2009 - 2022 Emory University, Founder of the Emory Pituitary Clinic for Endocrinology fellows
2009 - 2011 Emory University, Core lectures for internal medicine residents
2011 Emory University, Lectures in Endocrinology for Otolaryngology residents
2011 - 2020 Emory University, Lectures in Endocrinology for Reproductive Endocrinology fellows, 2011, 2013, 2016, 2017, 2018, 2020
2012 - 2022 Emory University, Case Conference of the week for endocrine fellows
2015 Emory University, Lectures in Endocrinology for Otolaryngology residents
2016 Emory University, Lectures in Endocrinology for Pulmonary Fellows
- 11/2024 AACE Endocrine University, Functioning Pituitary Adenomas
 
Continuing Medical Education
2008 - 2022 Periodical lectures in Neuroendocrinology for Nurses, Nurse Practitioners and Physician Assistants
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Ioachimescu OC, Ioachimescu AG, Iannini PB. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Int J Antimicrob Agents. 2004 Nov;24(5):485-90.
2. Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab. 2005 Feb;90(2):871-7.
3. Ioachimescu A, Licata A. Etidronate: What is its place in treatment of primary osteoporosis and other demineralizing diseases today? Current Osteoporosis Reports. December 2007;5(4):165-169.
4. Ioachimescu AG, Makdissi A, Lichtin A, Zimmerman RS. Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study. Thyroid. 2007 Nov;17(11):1137-42.
5. Tamaskar I, Bukowski R, Elson P, Ioachimescu AG, Wood L, Dreicer R, Mekhail T, Garcia J, Rini BI. Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib. Ann Oncol. 2008 Feb;19(2):265-8.
6. Ioachimescu AG, Brennan DM, Hoar BM, Kashyap SR, Hoogwerf BJ. Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study. Diabet Med. 2007 Dec;24(12):1369-74.
7. Ioachimescu AG, Bauer TW, Licata A. Active crohn disease and hypercalcemia treated with infliximab: case report and literature review. Endocr Pract. 2008;14(1):87-92.
8. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008 Feb;58(2):623-30.
9. Ioachimescu AG, Hoogwerf BJ. Comments on the letter by Pitocco et al. (Serum uric acid, mortality and glucose control in patients with type 2 diabetes mellitus: A PreCIS database study) Diabetic Medicine. April 2008;25(4):509.
10. Ioachimescu AG, Brennan DM, Hoogwerf BJ. Serum uric acid level reduction, cardiovascular outcome, and mortality: Comment on the article by Ioachimescu et al. - Reply Arthritis and Rheumatism. August 2008;58(8):2586.
11. Srivatsa S, Ioachimescu AG, Oyesiku NM, Hunter SB. Visual vignette. Endocr Pract. 2008 Dec;14(9):1192.
12. Kashyap SR, Ioachimescu AG, Gornik HL, Gopan T, Davidson MB, Makdissi A, Major J, Febbraio M, Silverstein RL. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring). 2009 Dec;17(12):2142-8. PMCID: PMC2836489
13. Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring). 2010 Sep;18(9):1836-44.
14. Ioachimescu AG, Hamrahian AH. Diseases of the Adrenal Gland Current Clinical Medicine: Expert Consult Premium Edition - Enhanced Online Features and Print. 1 January 2010:336-349.e1.
15. Pantalone KM, Gopan T, Remer EM, Faiman C, Ioachimescu AG, Levin HS, Siperstein A, Berber E, Shepardson LB, Bravo EL, Hamrahian AH. Change in adrenal mass size as a predictor of a malignant tumor. Endocr Pract. 2010;16(4):577-87.
16. Shah R, Licata A, Oyesiku NM, Ioachimescu AG. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: case reports and review of the literature. Pituitary. 2012 Dec;15 Suppl 1:S17-22.
17. Shah R, Schniederjan M, DelGaudio JM, Ioachimescu AG. Visual vignette. Ectopic ACTH-secreting pituitary adenoma. Endocr Pract. 2011;17(6):966.
18. Ioachimescu AG, Hamrahian AH, Stevens M, Zimmerman RS. The pituitary stalk transection syndrome: multifaceted presentation in adulthood. Pituitary. 2012 Sep;15(3):405-11.
19. Eiland L, Oyesiku NM, Ritchie JC, Isaacs S, Ioachimescu AG. Pathogenesis of marked pituitary enlargement and increased serum thyroid-stimulating hormone in primary hypothyroidism. Thyroid. 2012 Jan;22(1):101-2.
20. Muh CR, Ioachimescu AG, Oyesiku NM. Growth Hormone-Secreting Tumors Schmidek and Sweet Operative Neurosurgical Techniques: Indications, Methods, and Results: Sixth Edition. March 2012;1:215-220.
21. Ioachimescu AG, Eiland L, Chhabra VS, Mastrogianakis GM, Schniederjan MJ, Brat D, Pileggi AV, Oyesiku NM. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery. 2012 Aug;71(2):296-303; discussion 304.
22. Miller BA, Rutledge WC, Ioachimescu AG, Oyesiku NM. Management of large aggressive nonfunctional pituitary tumors: experimental medical options when surgery and radiation fail. Neurosurg Clin N Am. 2012 Oct;23(4):587-94.
23. Pasquel FJ, Vincentelli C, Brat DJ, Oyesiku NM, Ioachimescu AG. Pituitary carcinoma in situ. Endocr Pract. 2013;19(3):e69-73.
24. Janssen JAMJL, Van Der Lely AJ, Rogol AD, Ioachimescu AG. Hormone Replacement Therapy Pituitary Disorders: Diagnosis and Management. 8 March 2013:265-276.
25. Miller BA, Ioachimescu AG, Oyesiku NM. Clinically Nonfunctioning Pituitary Adenomas Pituitary Disorders: Diagnosis and Management. 8 March 2013:130-137.
26. Miller BA, Tanaka T, Ioachimescu AG, Vincentelli C, Appin CL, Oyesiku NM. Transformation of a Silent Adrencorticotrophic Pituitary Tumor Into Central Nervous System Melanoma. J Investig Med High Impact Case Rep. 2013;1(2):2324709613494008. PMCID: PMC4528794
27. Ioachimescu AG, Eiland L, Barrow DL. Visual vignette. Giant partially thrombosed left ophthalmic artery aneurysm. Endocr Pract. 2013;19(6):1070.
28. Ioachimescu AG, Hampstead BM, Moore A, Burgess E, Phillips LS. Growth hormone deficiency after mild combat-related traumatic brain injury. Pituitary. 2015 Aug;18(4):535-41.
29. Anthony JR, Ioachimescu AG. Acromegaly and bone disease. Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):476-82.
30. Miller BA, Ioachimescu AG, Oyesiku NM. Contemporary indications for transsphenoidal pituitary surgery. World Neurosurg. 2014 Dec;82(6 Suppl):S147-51.
31. Ioachimescu AG, Barrow DL. Subarachnoid Hemorrhage and the Pituitary. World Neurosurg. 2015 Jun;83(6):1026-8.
32. Ioachimescu AG, Remer EM, Hamrahian AH. Adrenal incidentalomas: a disease of modern technology offering opportunities for improved patient care. Endocrinol Metab Clin North Am. 2015 Jun;44(2):335-54.
33. Anthony JR, Alwahab UA, Kanakiya NK, Pontell DM, Veledar E, Oyesiku NM, Ioachimescu AG. SIGNIFICANT ELEVATION OF GROWTH HORMONE LEVEL IMPACTS SURGICAL OUTCOMES IN ACROMEGALY. Endocr Pract. 2015 Sep;21(9):1001-9.
34. Anthony J, Esper GJ, Ioachimescu A. Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review. Pituitary. 2016 Feb;19(1):19-29.
35. Azzalin A, Appin CL, Schniederjan MJ, Constantin T, Ritchie JC, Veledar E, Oyesiku NM, Ioachimescu AG. Comprehensive evaluation of thyrotropinomas: single-center 20-year experience. Pituitary. 2016 Apr;19(2):183-93.
36. Hedley JS, Law S, Phookan S, Lee MNF, Ioachimescu A, Levit RD. Pheochromocytoma masquerading as “diabetic ketoacidosis” Journal of Investigative Medicine High Impact Case Reports. 28 May 2016;4(2).
37. Pappy AL, Oyesiku N, Ioachimescu A. Severe TSH elevation and pituitary enlargement after changing thyroid replacement to compounded T4/T3 therapy Journal of Investigative Medicine High Impact Case Reports. July 2016;4(3).
38. Hage R, Eshraghi SR, Oyesiku NM, Ioachimescu AG, Newman NJ, Biousse V, Bruce BB. Third, Fourth, and Sixth Cranial Nerve Palsies in Pituitary Apoplexy. World Neurosurg. 2016 Oct;94:447-452. PMCID: PMC5064865
39. Ioachimescu AG. I suspect my patient has a thyrotropinoma: What’s next? The Art of Neuroendocrinology: A Case-Based Approach to Medical Decision-Making. 1 January 2017:417-422.
40. Ioachimescu AG. Impact of acromegaly treatment on cardiovascular complications. Endocrine. 2017 Mar;55(3):659-661.
41. Constantin T, Tangpricha V, Shah R, Oyesiku NM, Ioachimescu OC, Ritchie J, Ioachimescu AG. Calcium and Bone Turnover Markers in Acromegaly: A Prospective, Controlled Study. J Clin Endocrinol Metab. 2017 Jul 01;102(7):2416-2424.
42. Pujara S, Ioachimescu A. Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Journal of Investigative Medicine High Impact Case Reports. 1 May 2017;5(2).
43. Salvatori R, Gordon MB, Woodmansee WW, Ioachimescu AG, Carver DW, Mirakhur B, Cox D, Molitch ME. A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry. Pituitary. 2017 Dec;20(6):605-618.
44. Constantin T, Tangpricha V, Shah R, Oyesiku NM, Ioachimescu O, Ritchie J, Ioachimescu AG. Response to Letter: "Calcium and Bone Turnover Markers in Acromegaly: A Prospective, Controlled Study". J Clin Endocrinol Metab. 2017 Sep 01;102(9):3561-3562.
45. Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-Price J, Pasireotide G2304 Study Group. Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial. Lancet Diabetes Endocrinol. 2018 Jan;6(1):17-26.
46. Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease. A preventive cardiology information system (PreCIS) database cohort study Kardiologija v Belarusi. 2018;10(5):613-628.
47. Ioachimescu AG. Diabetes and Atherosclerotic Cardiovascular Disease. Endocrinol Metab Clin North Am. 2018 Mar;47(1):xiii-xiv.
48. Ioachimescu AG. Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease. Endocrinol Metab Clin North Am. 2018 Jun;47(2):335-347.
49. Ioachimescu AG. Cushing's Syndrome 2018: Best Practices and Looking Ahead. Endocrinol Metab Clin North Am. 2018 Jun;47(2):xiii-xiv.
50. Woodmansee WW, Gordon MB, Molitch ME, Ioachimescu AG, Carver DW, Mirakhur B, Cox D, Salvatori R. Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis. Endocrine. 2018 Jul;61(1):105-117. PMCID: PMC5997114
51. Ioachimescu A. TSH-STAINING PITUITARY ADENOMA: A RARE ENTITY WITH CHANGING FACETS. Endocr Pract. 2018 Jun;24(6):602-604.
52. Ioachimescu AG. Management of Neuroendocrine Tumors in the Twenty-First Century. Endocrinol Metab Clin North Am. 2018 Sep;47(3):xiii-xiv.
53. Ioachimescu AG. Hypoparathyroidism. Endocrinol Metab Clin North Am. 2018 Dec;47(4):xiii.
54. Ioachimescu AG, Fleseriu M, Hoffman AR, Vaughan Iii TB, Katznelson L. Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. Eur J Endocrinol. 2019 Jan 01;180(1):31-40.
55. Ioachimescu AG. Thyroid Cancer. Endocrinol Metab Clin North Am. 2019 Mar;48(1):xv-xvi.
56. Braileanu M, Hu R, Hoch MJ, Mullins ME, Ioachimescu AG, Oyesiku NM, Pappy A 2nd, Saindane AM. Pre-operative MRI predictors of hormonal remission status post pituitary adenoma resection. Clin Imaging. 2019;55:29-34.
57. Gonzalez A, Saindane AM, Neill SG, Oyesiku NM, Ioachimescu AG. The Intriguing Case of a Double Pituitary Adenoma. World Neurosurg. 2019 Jun;126:331-335.
58. Benito-Martínez E, Galeano-Valle F, González A, Edgar MA, Oprea-Ilies G, Ioachimescu AG, Pasquel FJ. Ectopic ACTH Syndrome With Association of Multiple Pulmonary Sclerosing Pneumocytomas and Multiple Carcinoid Tumorlets. J Endocr Soc. 2019 May 01;3(5):937-942. PMCID: PMC6469949
59. Ioachimescu AG. Transgender Medicine. Endocrinol Metab Clin North Am. 2019 Jun;48(2):xiii-xiv.
60. Ioachimescu AG. Pregnancy and Endocrine Disorders. Endocrinol Metab Clin North Am. 2019 Sep;48(3):xiii-xiv.
61. Pappy AL 2nd, Savinkina A, Bicknese C, Neill S, Oyesiku NM, Ioachimescu AG. Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients. Pituitary. 2019 Oct;22(5):520-531.
62. Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Ioachimescu A, Katznelson L, Kelestimur F, Kopchick J, Krsek M, Lamberts S, Losa M, Luger A, Maffei P, Marazuela M, Mazziotti G, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn S, Puig-Domingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, van der Lely AJ, Wass J, Zatelli MC, Melmed S. A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update. J Clin Endocrinol Metab. 2020 Apr 01;105(4).
63. Ioachimescu AG. Updates in Endocrine Hypertension. Endocrinol Metab Clin North Am. 2019 Dec;48(4):xiii-xiv.
64. Ioachimescu AG, Handa T, Goswami N, Pappy AL 2nd, Veledar E, Oyesiku NM. Gender differences and temporal trends over two decades in acromegaly: a single center study in 112 patients. Endocrine. 2020 Feb;67(2):423-432.
65. Ioachimescu AG. Technological Advances in Management of Diabetes Mellitus. Endocrinol Metab Clin North Am. 2020 Mar;49(1):xiii-xiv.
66. Ioachimescu AG. Obesity: A Closer Look. Endocrinol Metab Clin North Am. 2020 Jun;49(2):xi-xii.
67. Agrawal N, Ioachimescu AG. Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review. Pituitary. 2020 Oct;23(5):582-594.
68. Ioachimescu AG. Pituitary Endocrinology in 2020: An Update. Endocrinol Metab Clin North Am. 2020 Sep;49(3):xv-xvi.
69. Giraldi EA, Ioachimescu AG. The Role of Dopamine Agonists in Pituitary Adenomas. Endocrinol Metab Clin North Am. 2020 Sep;49(3):453-474.
70. Na S, Fernandes MA, Ioachimescu AG, Penna S. Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome. Behav Neurol. 2020;2020:4064370. PMCID: PMC7428886
71. Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S. Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord. 2020 Dec;21(4):667-678. PMCID: PMC7942783
72. Giraldi EA, Veledar E, Oyesiku NM, Ioachimescu AG. Incidentally detected acromegaly: single-center study of surgically treated patients over 22 years. J Investig Med. 2021 Feb;69(2):351-357.
73. Ioachimescu AG. Androgens in Women: Too Much, Too Little, Just Right. Endocrinol Metab Clin North Am. 2021 Mar;50(1):xiii-xiv.
74. Ioachimescu AG. Updates on Osteoporosis. Endocrinol Metab Clin North Am. 2021 Jun;50(2):ix-x.
75. Ioachimescu AG. Acromegaly: achieving timely diagnosis and improving outcomes by personalized care. Curr Opin Endocrinol Diabetes Obes. 2021 Aug 01;28(4):419-426.
76. Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Christ-Crain M, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, “Pituitary Society Delphi Collaborative Group”. Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas. Pituitary. 2022 Feb;25(1):64-73. PMCID: PMC8294287
77. Ioachimescu AG. A Population-Based Approach to Diabetes and Prediabetes. Endocrinol Metab Clin North Am. 2021 Sep;50(3):xv-xvi.
78. Wang A, Neill SG, Newman S, Tryfonidou MA, Ioachimescu A, Rossi MR, Meij BP, Oyesiku NM. The genomic profiling and MAMLD1 expression in human and canines with Cushing's disease. BMC Endocr Disord. 2021 Sep 13;21(1):185. PMCID: PMC8438999
79. Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Kelly DF, Lacroix A, McCormack A, Melmed S, Molitch M, Mortini P, Newell-Price J, Nieman L, Pereira AM, Petersenn S, Pivonello R, Raff H, Reincke M, Salvatori R, Scaroni C, Shimon I, Stratakis CA, Swearingen B, Tabarin A, Takahashi Y, Theodoropoulou M, Tsagarakis S, Valassi E, Varlamov EV, Vila G, Wass J, Webb SM, Zatelli MC, Biller BMK. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. PMCID: PMC8743006
80. Ioachimescu AG. Hypercalcemia and its Multiple Facets. Endocrinol Metab Clin North Am. 2021 Dec;50(4):xiii-xiv.
81. Giraldi EA, Neill SG, Mendoza P, Saindane A, Oyesiku NM, Ioachimescu AG. Functioning Crooke Cell Adenomas: Case Series and Literature Review. World Neurosurg. 2022 Feb;158:e754-e765.
82. Ioachimescu AG, Goswami N, Handa T, Pappy A, Veledar E, Oyesiku NM. Racial Disparities in Acromegaly and Cushing's Disease: A Referral Center Study in 241 Patients. J Endocr Soc. 2022 Jan 01;6(1):bvab176. PMCID: PMC8677529
83. Janopaul-Naylor JR, Rupji M, Zhong J, Eaton BR, Ali N, Ioachimescu AG, Oyesiku NM, Shu HG. Modern Linear Accelerator-Based Radiotherapy Is Safe and Effective in the Treatment of Secretory and Nonsecretory Pituitary Adenomas. World Neurosurg. 2022 Apr;160:e33-e39. PMCID: PMC8977244
84. Greven ACMC, Douglas JM, Couceyro J, Nakirikanti A, Dawoud R, Revuelta-Barbero M, Ward E, Giraldi EA, Ioachimescu A, Hoang KB, Bray DP, Oyesiku NM. Telemedicine for Neurosurgery Consultations at a Pituitary Center of Excellence: Patient Preference and Willingness to Proceed with Surgery Journal of Neurological Surgery, Part B: Skull Base. 2022.
85. Ioachimescu AG. Updates in Male Hypogonadism. Endocrinol Metab Clin North Am. 2022 Mar;51(1):xiii-xiv.
86. Ioachimescu AG, Goswami N, Handa T, Pappy A, Veledar E, Oyesiku NM. Erratum : Racial Disparities in Acromegaly and Cushing's Disease: A Referral Center Study in 241 Patients (J Endo Society (2022) 6: 1 DOI: 10.1210/jendso/bvab176) Journal of the Endocrine Society. 1 May 2022;6(5).
87. Ioachimescu AG. Thyroid Disorders: An Update. Endocrinol Metab Clin North Am. 2022 Jun;51(2):xiii-xiv.
88. Ioachimescu AG. Advances in Lipids. Endocrinol Metab Clin North Am. 2022 Sep;51(3):xiii-xiv.
89. Ioachimescu AG. Importance of Patient-Reported Outcomes in Endocrinology. Endocrinol Metab Clin North Am. 2022 Dec;51(4):xi-xiii.
90. Giraldi E, Allen JW, Ioachimescu AG. Pituitary Incidentalomas: Best Practices and Looking Ahead. Endocr Pract. 2023 Jan;29(1):60-68.
91. Ioachimescu AG. Diabetes Remission. Endocrinol Metab Clin North Am. 2023 Mar;52(1):xiii-xiv.
92. Chiara M Bettale, Jason W Allen, Zaid K Mahdi, Adriana G Ioachimescu. Pancreatic ACTH Hypersecretion and Pituitary Macroadenoma JCEM Case Reports. https://doi.org/10.1210/jcemcr/luad007.
93. Medina EJ, Zohdy YM, Porto E, Revuelta Barbero JM, Bray D, Maldonado J, Rodas A, Mayol M, Morales B, Neill S, Read W, Pradilla G, Ioachimescu A, Garzon-Muvdi T. Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas Frontiers in Endocrinology. 2023;14.
94. Ioachimescu AG. Sociodemographic Factors in Pituitary Adenomas Endocrinology and Metabolism Clinics of North America. 2023.
95. Ioachimescu AG. Impact of Repetitive and Traumatic Brain Injury on Pituitary Function Pituitary Disorders throughout the Life Cycle: A Case-Based Guide. 1 January 2022:297-308.
96. Samson SL, Ioachimescu AG. Pituitary Disorders throughout the Life Cycle: A Case-Based Guide Pituitary Disorders throughout the Life Cycle: A Case-Based Guide. 1 January 2022:1-403.
97. Armstrong SA, Tavakoli S, Shah I, Laing BR, Coss D, Ioachimescu AG, Findling J, Zwagerman NT. Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case. J Neurosurg Case Lessons. 2023 Nov 27;6(22). PMCID: PMC10684060
98. Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Molitch M, Muir CA, Neggers S, Pereira AM, Pivonello R, Post K, Raverot G, Salvatori R, Samson SL, Shimon I, Spencer-Segal J, Vila G, Wass J, Melmed S. Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2024 Jan;20(1):62.
99. Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, Bronstein M, Chanson P, Fukuoka H, Gadelha M, Greenman Y, Gurnell M, Ho KKY, Honegger J, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Lodish M, Maiter D, Marcus HJ, McCormack A, Molitch M, Muir CA, Neggers S, Pereira AM, Pivonello R, Post K, Raverot G, Salvatori R, Samson SL, Shimon I, Spencer-Segal J, Vila G, Wass J, Melmed S. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023 Dec;19(12):722-740.
100. Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Banfi G, Barkan A, Beckers A, Bidlingmaier M, Boguszewski C, Brue T, Buchfelder M, Chanson P, Chiloiro S, Colao A, Coopmans E, Esposito D, Ferone D, Frara S, Gadelha M, Geer EB, Ghigo E, Greenman Y, Gurnell M, Ho K, Ioachimescu A, Johannsson G, Jørgensen JO, Kaiser UB, Karavitaki N, Katznelson L, Lamberts S, Losa M, Luger A, Luque R, Maffei P, Marazuela M, Neggers S, Pereira A, Persani L, Petersenn S, Reincke M, Salvatori R, Samson SN, Schilbach K, Shimon I, Tsagarakis S, Zatelli MC. Consensus on criteria for acromegaly diagnosis and remission Pituitary. 2023.
101. Samson SL, Ioachimescu AG. Preface Pituitary Disorders throughout the Life Cycle: A Case-Based Guide. 1 January 2022:vii-vii.
102. Zhang CD, Ioachimescu AG. Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome Frontiers in Endocrinology. 2024;15.
103. Ioachimescu AG. Sociodemographic Factors in Pituitary Adenomas. Endocrinol Metab Clin North Am. 2023 Dec;52(4):705-717.
104. Bettale CM, Allen JW, Mahdi ZK, Ioachimescu AG. Pancreatic ACTH Hypersecretion and Pituitary Macroadenoma. JCEM Case Rep. 2023 Jan;1(1):luad007. PMCID: PMC10578389
105. Zhang CD, Ioachimescu AG. Prolactinomas: Preconception and During Pregnancy Endocrinology and Metabolism Clinics of North America. September 2024;53(3):409-419.
106. Gonzalez R, Massman L, Ho S, Luna S, Cheok S, Liang B, Mrachek K, Coss D, Ioachimescu AG, Zwagerman N, Olivier-Van Stichelen S. The diverging role of O-GlcNAc transferase in corticotroph and somatotroph adenomas. Pituitary. 2024 Oct;27(5):577-589.
107. Zhang CD, Ioachimescu AG. Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome. Front Endocrinol (Lausanne). 2024;15:1353543. PMCID: PMC11045978
108. Giraldi EA, Saindane A, Pradilla G, Biousse V, Ioachimescu AG. TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA. Acta Endocrinol (Buchar). 2023;19(3):339-344. PMCID: PMC10863970
109. Ioachimescu AG, Kelestimur F. Drug induced hypoprolactinemia. Rev Endocr Metab Disord. 2024 Dec;25(6):1003-1011.
110. Zhang CD, Ioachimescu AG. Prolactinomas: Preconception and During Pregnancy. Endocrinol Metab Clin North Am. 2024 Sep;53(3):409-419.
111. Allen ME, Beck RT, Zwagerman NT, Coss D, Fisco A, Ioachimescu AG. Isolated IgG4-related Infundibulo-hypophysitis. JCEM Case Rep. 2024 Oct;2(10):luae182. PMCID: PMC11482006
112. Cheok SK, Tavakoli-Sabour S, Beck RT, Zwagerman N, Ioachimescu A. Ends of the spectrum best practices for early detection and multidisciplinary management of acromegaly. J Neurooncol. 2025 Jan;171(1):1-9.
113. Fernandes MA, Hickle SD, Penna S, Ioachimescu AG, Tone EB. Comparative Analysis of Cognitive and Psychiatric Functioning in People With Cushing's Disease in Biochemical Remission and People With Nonfunctioning Adenomas. Behav Neurol. 2024;2024:4393169. PMCID: PMC11578661
114. Kelestimur F, Ioachimescu AG. Hypoprolactinemia, a neglected endocrine disorder. Rev Endocr Metab Disord. 2024 Dec;25(6):941-942.
 
Abstracts
1. Ioachimescu AG*, Makdissi A, Lichtin A, Zimmerman R. Thrombocytopenia in Autoimmune Thyroid Disease: Case presentations and Review of the literature. 14th AACE Annual Meeting and Clinical Congress, Washington DC, 2005. (oral presentation)
2. Ioachimescu AG*, Zimmerman R. Pituitary Stalk Transection Syndrome Diagnosed in Adulthood: 2 Cases and Review of literature. 16th AACE Annual Meeting and Clinical Congress, Chicago, IL, 2006. (poster presentation)
3. Ioachimescu AG*, Licata A. Hypercalcemia caused by active Crohn’s disease. 16th AACE Annual Meeting and Clinical Congress, Chicago, IL, 2006. (poster presentation)
4. Ioachimescu AG*, Kashyap S, Hoogwerf B. Serum uric acid, mortality and glucose control in patients with type 2 diabetes mellitus: a PreCIS data base study. American Diabetes Association Annual Meeting, Washington DC, 2007. (poster presentation)
5. Ioachimescu AG*, Brennan D, Hoar B, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS cohort study. 90th Endocrine Society Meeting, San Francisco, CA, 2008 (oral presentation and Mara Lieberman Award for outstanding abstracts submitted by women)
6. Ioachimescu AG*, Chhabra V, Schniederjan M, Brat D, Oyesiku NM. Silent Corticotroph Adenoma: A Cohort Study of 40 Patients Operated at Emory University. 11th International Pituitary Congress, Washington DC, 2009. (poster presentation)
7. Shah R*, Oyesiku NM and Ioachimescu AG. Acromegaly as a cause of calcitriol-dependent hypercalcemia. 19th AACE Annual Meeting and Clinical Congress, Boston, 2010. (poster presentation)
8. Ioachimescu AG*, Pimentel D, Chabbra V, Oyesiku NM. Outcome study of trans-sphenoidal surgery in acromegaly: Emory University experience. 19th AACE Annual Meeting and Clinical Congress, Boston, 2010. (poster presentation)
9. Eiland L*, Oyesiku NM, Ritchi JC, Isaacs S, Ioachimescu AG. Severely elevated TSH level and pituitary enlargement in a patient with primary autoimmune hypothyroidism: case report and review of literature. Southern Regional Meeting, New Orleans, LA, 2011. (poster presentation)
10. Shah R*, Schniederjan M, DelGaudio JM, Ioachimescu AG. Cushing’s disease due to an ectopic clival pituitary adenoma. Southern Regional Meeting, New Orleans, LA, 2011. (poster presentation)
11. Ioachimescu AG*, Hampstead BH, Moore A, Burgess E, Phillips LS. Growth Hormone Deficiency in Veterans with Traumatic Brain Injury: An Atlanta VAMC Pilot Study. Endocrine Society, 94th Annual Meeting, Houston, TX, 2012. (poster presentation)
12. Ioachimescu AG, Mastrogianakis GM, Quaynor S, Oyesiku NM. Outcomes of Trans-sphenoidal Surgery in Patients with Prolactinomas: Emory University Experience. Endocrine Society, 94th Annual Meeting, Houston, TX, 2012. (poster presentation)
13. Barb D*, Pasquel FJ, Vincentelli C, Holder C, Oyesiku NM, Ioachimescu AG. Diffuse B-cell Lymphoma ing as a Pituitary Mass. Endocrine Society, 94th Annual Meeting, Houston, TX, 2012. (poster presentation)
14. FJ Pasquel*, C Vincentelli, NM Oyesiku, DJ Brat and AG Ioachimescu, Fatal pituitary carcinoma. Southern Regional Meeting, New Orleans, LA, 2012 (oral presentation, Trainee Research Award Winner)
15. Constantin T*, Oyesiku NM, Ioachimescu AG. A Case of Pituitary Adenoma presenting as Atrial Fibrillation. 23rd AACE Annual Meeting and Clinical Congress, Las Vegas, NE, 2013. (poster presentation)
16. Anthony J*, Esper GJ, Ioachimescu A. Hypothalamic sarcoidosis with vision loss and hypopituitarism – case series and review of literature. Southern Regional Meeting, New Orleans, LA, 2014 (oral presentation, Trainee Research Award Winner)
17. Anthony J*, Alwahab U, Kanakiya NK, Pimentel DM, Veledar E, Oyesiku NM, Ioachimescu AG. Severely Elevated Growth Hormone Levels Impact Surgical Outcomes in Acromegaly- Emory University Experience. 23th AACE Annual Meeting and Clinical Congress, Las Vegas, NE, 2014. (poster presentation)
18. Alice Azzalin*, Christina Appin, Rachel Puttnam, James C. Ritchie, Daniel Brat, Oyesiku NM, Ioachimescu AG. Pleiotropic manifestations of TSH-secreting pituitary adenomas: Emory University case series. Endocrine Society, 96th Annual Meeting, Las Vegas, NE, 2014. (poster presentation)
19. Constantin T*, Tangpricha V, Reshma Shah, Ioachimescu OC, Oyesiku NM, Ioachimescu AG. Calcium and Bone Turnover Alterations in Patients with Acromegaly: A Prospective Controlled Study. Endocrine Society, 97th Annual Meeting, San Diego, CA, 2015. (oral presentation)
20. Constantin T*, Tangpricha V, Shah R, Ioachimescu O, Oyesiku N, Ioachimescu AG. Calcium perturbations and bone turnover in patients with acromegaly: a prospective controlled study. Southern Regional Meeting, New Orleans, LA, 2015 (oral presentation, Trainee Research Award Winner)
21. Anthony JR*, Brat D, Ioachimescu OC, Oyesiku NM, Ioachimescu AG. Prognostic Significance of Markers of Histological Atypia in Acromegaly: an Emory University extended cohort series. Endocrine Society, 97th Annual Meeting, San Diego, CA, 2015. (poster presentation)
22. Azzalin A*, Appin, Schniederjan M, Constantin T,Baum GR, Ritchie JC, Oyesiku NM, Ioachimescu AG. Comprehensive Evaluation of Thyrotropinomas: Emory University 20-year experience. 25th AACE Annual Meeting and Clinical Congress, Nashville, TN, 2015. (poster presentation and second prize and a travel award)
23. Ioachimescu AG*, Anthony JR, Veledar E, Ioachimescu OC, Barrow DL, Oyesiku NM, Brat D. Correlation of tumor markers with clinical outcomes in patients with acromegaly: a single center experience. Endocrine Society, 98th Annual Meeting, Boston, MA, 2016. (poster presentation)
24. Constantin T*, Shah R, Abd Alwahab U, Veledar E, Oyesiku NM, Ioachimescu AG. Prediction models in Cushing’s disease: single institution cohort study in 108 operated patients. Endocrine Society, 98th Annual Meeting, Boston, MA, 2016. (poster presentation)
25. Ioachimescu AG*, Joseph A, Veledar E, Oyesiku NM. Surgical outcomes and prognostic factors in patients with prolactinomas: a single-center consecutive case series. 26th AACE Annual Meeting and Clinical Congress, Boston, MA, 2016. (poster presentation)
26. Pappy AL 2nd*, Oyesiku N, Ioachimescu A. Severe TSH elevation and pituitary enlargement after changing thyroid replacement to compounded T4/T3 therapy. Southern Regional Meeting, New Orleans, LA, 2016 (oral presentation, Trainee Research Award Winner)
27. Gordon MB*, Molitch M, Woodmansee WW, Ioachimescu A, Carver D, Mirakhur B, Cox D, Salvatori R. Body mass index as one of the determinants of biochemical control in acromegaly: 2-year data from the SODA registry. Endocrine Society, 99th Annual Meeting, Orlando, FL, 2017 (poster presentation)
28. Ioachimescu AG*, Ownby JA, Greyshock NG, Jones TC, Wand GA, and Smith JJ. Improving glycemic control with mifepristone in Cushing’s syndrome may lead to significant weight loss. 27th AACE Annual Meeting and Clinical Congress, Austin, TX, 2017. (poster presentation)
29. Pappy II, AL, Bicknese C, Ridley DE, Savinkina, S, Vigneswaran K, Stewart, N, Oyesiku NM, Ioachimescu AG. “Tumor Markers, Cavernous Sinus Invasion and Surgical Outcomes in 501 Consecutive Patients with Pituitary Adenomas: An Appraisal of the 2017 WHO Classification Updates”. Late-breaking abstract, Endocrine Society, 100th Annual Meeting, Boston, MA, 2018 (poster presentation)
30. Gonzales A, Saindane AM, Oyesiku NM, Ioachimescu AG. The intriguing case of double pituitary adenoma in a patient receiving prednisone. 28th AACE Annual Meeting and Clinical Congress, Boston, MA, 2018. (poster presentation)
31. Gonzales A, Brat DJ, Veledar E, Oyesiku NM, Barrow DL, Ioachimescu AG. Tumor markers in functional and silent corticotroph adenomas. 28th AACE Annual Meeting and Clinical Congress, Boston, MA, 2018. (poster presetation and fellow travel award)
32. Handa T, Goswami N, Bicknese C, Pappy A, Veledar E, Oyesiku NM, Ioachimescu AG. Gender differences and outcome trends over two decades in acromegaly: a single center study in 112 patients. 28th AACE Annual Meeting and Clinical Congress, Boston, MA, 2018 (poster presentation)
33. Bicknese, C., McLemore, M, Ioachimescu, A: Langerhans Cell Histiocytosis Wrecks Havoc on the Hypothalamus. Southern Regional Meeting, New Orleans, LA, 2018 (oral presentation, Student Travel Award)
34. Ioachimescu AG, Pappy AL, Savinkina A, Neill S, Oyesiku NM. Surgical outcomes in 501 pituitary adenomas: predictive value of tumor markers and cavernous sinus invasion. Single center experience. International Congress of Endocrinology, Cape Town, South Africa (oral presentation)
35. Giraldi E, Veledar E, Oyesiku NM and Ioachimescu AG. Cushing’s disease in men: a 20 year single center experience. 16th Congress Pituitary Society, New Orleans, LA, 2019 (poster presentation)
36. Goswami N, Handa T, Pappy A, Veledar E, Oyesiku NM, Ioachimescu AG. Racial Distribution, Presentation and Outcome in Acromegaly and Cushing's Disease: A Tertiary Referral Center Study in 220 Patients. Late-breaking abstract, Endocrine Society, 101th Annual Meeting, New Orleans, LA, 2019 (poster presentation)
37. Giraldi E, Veledar E, Nelson M. Oyesiku NM, Ioachimescu AG. Incidental detection of GH-secreting adenomas in a cohort of 112 patients undergoing transsphenoidal surgery. AACE virtual (due to Covid-19) poster presentation and fellow award
38. Ioachimescu AG. Pituitary Year in Review. AACE Master Class series 2020
39. Ioachimescu AG. Gender-Specific Characteristics in Acromegaly. AACE Master Class series 2020
40. Ioachimescu AG. Pituitary Year in Review. AACE 30th Annual Scientific Meeting 2021
41. Giraldi E, Neill S, Mendoza P, Oyesiku NMO, Ioachimescu AG. Crooke cell adenomas in patients with Cushing’s disease: a tertiary care center experience. AACE 30th Annual Scientific Meeting, 2021 (poster presentation)
42. Ioachimescu AG, Edwin L, Dahm A. Covid-19 response in Cushing’s community: a report from the membership of the Cushing’s Support & Research Foundation, a patient advocacy organization. Annual AACE Meeting, 2021 (poster presentation)
43. Giraldi E, Saindane A, Pradilla G, Ioachimescu AG. “Frontal Lobe Herniation and New Chiasmopathy: Rare Complications of Dopamine Agonist Therapy in Large Prolactinomas”. Annual AACE Meeting, 2022 (poster presentation)
44. Auchus RJ, Fleseriu M, Huang W, Spencer-Segal JL, Yuen KCJ, FACE4*, Dacus KC, Ludlam WH, Babler EK, Das AK, Campos C, Broder MS, Ioachimescu AG. Management, Safety, And Efficacy Of Osilodrostat Treatment In US Patients With Non-pituitary Cushing’s Syndrome: Results From The ILLUSTRATE Study. Endocrine Society Annual Meeting 2022 (late breaking abstract and poster presentation)
45. Ioachimescu AG, Auchus RJ, Huang W, Spencer-Segal JL, Yuen KCJ, Dacus KC, Ludlam WH, Babler EK, Das AK, Campos C, Broder MS, Fleseriu M. Dosing And Titration Of Osilodrostat In A Real-world Cohort Of US Patients With Endogenous Cushing’s Disease: Analysis Of The ILLUSTRATE Study. Endocrine Society Annual Meeting 2022 (late breaking abstract and poster presentation)
46. Logan J Massman, MD, MS, Roel Gonzalez, BS, Brandon Laing, MD, Dylan Coss, MD, Adriana Gabriela Ioachimescu, MD, PhD, Nathan Zwagerman, MD, and Stephanie Olivier-Van Stichelen, Ph.D, "Uncovering The Role Of O-glcnacylation In Pituitary Adenoma Pathogenesis: Insights From Corticotroph Tumors", Endocrine Society Annual Meeting, June 2023
47. Margaret Allen, Ryan T. Beck, Nathan T. Zwagerman, Dylan Coss, Amy Fisco, Adriana G. Ioachimescu AG, "Isolated IgG4-Related Infundibulo-Hypophysitis", Endocrine Society Annual Meeting, June 2024
48. Yuen K CJ, Huang W, Fleseriu M, Geer EB, Araki T, Labadzhyan A, Freda PU, Ioachimescu AG, Cristofides EA, Sisco J, Biermasz NR, Crompton JA, Molitch ME, "Real-world biochemical and symptoms outcomes with oral octreotide: Management of ACROmegaly (MACRO) registry experience, Endocrine Society Annual Meeting, June 2024